| 发明名称 |
METHOD OF TREATING CANCER |
| 摘要 |
The present invention relates to a pharmaceutical composition comprising a histone-lysine N-methyltransferase EZH2 (enhancer of zeste homolog 2) inhibitor and an enhancer of interferon-gamma receptor activity. The invention also relates to method of treating a patient having cancer, comprising administration of the pharmaceutical composition. |
| 申请公布号 |
EP2908843(A4) |
申请公布日期 |
2016.12.14 |
| 申请号 |
EP20130855314 |
申请日期 |
2013.11.19 |
| 申请人 |
Agency for Science, Technology and Research |
发明人 |
YU, Qiang;WEE, Zhen Ning |
| 分类号 |
A61K38/21;A61K31/437;A61K31/52;A61K31/706;A61K31/713;A61P35/00;C07K14/555;C07K14/715;C07K16/40;C12N15/113;C12Q1/68;G01N33/574 |
主分类号 |
A61K38/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
